Medical Membrane Devices: Markets and Technologies

Published - Jan 2012| Analyst - Susan Hanft| Code - MST043E
Market Research Report Single User License: $2750 Member Price: FREE

Report Highlights

The U.S. medical membrane device market was valued at $2.1 billion in 2010 and is expected to be nearly $2.2 billion by the end of 2011. This market is forecast to grow to $2.9 billion by 2016, a compound annual growth rate (CAGR) of 5%.

 

SCOPE OF REPORT

Five-year projections for market activity and value are provided for the U.S. market.  Industry structure, device applications and trends, pricing considerations, research and development (R&D), environmental influences, companies, and competitive technologies are included in the study.

To simplify and focus on the most promising and clearly relevant technologies, the study concentrates on existing and potentially major uses of the technology.  The membranes used in medical devices work in tandem with other materials and processes, adding critical functionality and value.  To clarify the dynamic, the report addresses the membrane component of each sector in context with the market dynamics of the overall technology.  The report includes comparison of costs for various membrane materials and devices.  Current and potential market players are identified and examined.

Analyst Credentials

During the past 17 years, Susan Hanft has authored more than 35 market research reports for BCC Research in the fields of membrane technology, water and wastewater treatment, and separations used in food and beverage manufacture, medicine, biotechnology, and energy.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Jul-2009| Analyst - Susan Hanft| Code - MST043D

Report Highlights

  • The medical membrane device market, which includes dialyzers, blood oxygenators, IV filters and blood/apheresis filters, is valued at nearly $2 billion in 2009 and is expected to increase at a compound annual growth rate (CAGR) of 4.6% through 2014
  • Sales of dialyzers and blood oxygenators and IV filters are primarily market-driven, while sales of blood/apheresis filters and diagnostic devices are principally technology-driven
  • Sales of diagnostic devices continue to skyrocket. Applauded by managed care, a growing number of point-of-care (POC) and home tests are available for a host of new and existing applications.
Published - May-2007| Analyst - Susan Hanft| Code - MST043C

Report Highlights

  • The medical membrane device market, including dialyzers, blood oxygenators, IV filters and blood/apheresis filters, is valued at nearly $1.8 billion in 2007 and is increasing at a compound annual growth rate (CAGR) of 5.3% to reach $ 2.3 billion in 2012.
  • The combined worth of market-driven devices is about $623 million, rising at a compound annual growth rate of 3.6%. More than 235,000 U.S. kidney patients require dialysis on an ongoing basis to maintain renal function. Growth in the hemodialyzer market is driven by an increasing patient population, the phaseout of reusable dialyzers and the discovery that nonmembrane home dialysis may be applicable to a broader target audience
  • Technology driven products, such as blood/apheresis microfilters and diagnostic devices, have a combined value of $1.1 billion, with a 6.2% CAGR. Sales of these products for the most part, are spurred by improvements in design and materials, and by new applications.
Published - Jan-2002| Analyst - Susan Hanft| Code - MST043B

Report Highlights

  • The U.S. medical membrane device market is valued at $1.7 billion in 2001.
  • Increasing at an average annual growth rate (AAGR) of 7.1%, this market is expected to reach nearly $2.5 billion in 2006.
  • Sales of dialyzers and blood oxygenators, and increasingly leukofilters, are primarily market driven and are valued at $883 million in 2001 and growing at an AAGR 8.1%.
  • Sales of IV filters, blood/apheresis filters and diagnostic devices are principally technology driven and have a combined value of $859 million, with a 5.9% AAGR.
  • Sales of diagnostic devices have skyrocketed, driven by managed care, point-of-care and home tests for a host of applications.

CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report